When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation TherapyMay 14th 2019
This review summarizes the current evidence supporting the use of SBRT as treatment for inoperable renal cell carcinoma, as well as provides recommendations for patient selection and reviews the technical aspects of treatment and the expected toxicities.
The Role of Primary Tumor Treatment and Metastasis-Directed Therapy in Oligometastatic Prostate CancerMay 14th 2019
This case looks at an otherwise healthy 59-year-old man who was recently diagnosed with clinical stage IVB prostate adenocarcinoma. What is the most appropriate management for this patient?
Novel Targets and Precision Medicine for Prostate Cancer-Part 2: Tumor Profiling and Personalized Therapy in Patients With Castration-Resistant Prostate CancerApril 15th 2019
In this article, we review the current use of and future direction for genetic testing and tumor profiling in patients with metastatic castration-resistant prostate cancer.
Integrating Novel Targets and Precision Medicine Into Prostate Cancer Care-Part 1: The Non-Androgen–Targetable Pathways in Castration-Resistant Prostate CancerMarch 13th 2019
Here, we review the current use and future direction of novel therapeutic targets in the treatment of castration-resistant prostate cancer.